Ratings by Leerink (Lili Nsongo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2026 | Opus Genetics | IRD | New Coverage | Outperform (N/A) |
4.44 (4.08) |
-8.11% | Details | |
| 11/10/2025 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2025 | Arcturus Therapeutics | ARCT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2025 | Arcturus Therapeutics | ARCT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2024 | Voyager Therapeutics | VYGR | New Coverage | Outperform (N/A) |
6.85 (3.70) |
-45.99% | Details | |
| 8/12/2024 | Arcturus Therapeutics | ARCT | New Coverage | Outperform (N/A) |
18.08 (7.08) |
-60.84% | Details |
